Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules

Studies on a variety of chemical carcinogens have demonstrated that their ultimate reactive and carcinogenic forms are strong electrophiles. Some carcinogens, such as alkylating agents, are in their ultimate forms as administered, but most require metabolism to these active derivatives. The ultimate carcinogens react, usually non‐enzymatically, with nucleophilic constituents in vivo. Of particular interest in regard to their possible importance in carcinogenesis have been the covalent interactions of these electrophilic reactants with cellular informational macromolecules, the DNAs, RNAs, and proteins. Current data are consistent with the idea that the initiation step of chemical carcinogenesis is a mutagenic event and is caused by alteration of DNA by the ultimate carcinogens. The nature of the carcinogen metabolite(s) involved in the promotion phase has not been determined, but there appears to be no requirement that they be electrophilic. The development of the concept of ultimate chemical carcinogens as strong electrophilic reactants is reviewed, especially with respect to the studies carried out in the authors' laboratory.

[1]  I. Berenblum Cancer prevention as a realizable goal , 1981, Cancer.

[2]  I. Weinstein,et al.  Differential excision from DNA of the C-8 and N2 guanosine adducts of N-acetyl-2-aminofluorene by single strand-specific endonucleases. , 1977, Cancer research.

[3]  B. Ketterer INteractions between carcinogens and proteins. , 1980, British medical bulletin.

[4]  J. Clemmesen On the etiology of some human cancers. , 1951, Journal of the National Cancer Institute.

[5]  E. Kriek Persistent binding of a new reaction product of the carcinogen N-hydroxy-N-2-acetylaminofluorene with guanine in rat liver DNA in vivo. , 1972, Cancer research.

[6]  J. Radomski,et al.  Bladder Cancer Induction by Aromatic Amines: Role of N-Hydroxy Metabolites , 1970, Science.

[7]  E. Miller,et al.  The Mutagenicity of Chemical Carcinogens: Correlations, Problems, and Interpretations , 1971 .

[8]  J. Miller,et al.  The metabolic activation of the carcinogen 1'-hydroxysafrole in vivo and in vitro and the electrophilic reactivities of possible ultimate carcinogens. , 1976, Cancer research.

[9]  A. Loveless,et al.  Possible Relevance of O–6 Alkylation of Deoxyguanosine to the Mutagenicity and Carcinogenicity of Nitrosamines and Nitrosamides , 1969, Nature.

[10]  I. Purchase,et al.  An evaluation of 6 short-term tests for detecting organic chemical carcinogens. , 1978, British Journal of Cancer.

[11]  J. Miller,et al.  THE CARCINOGENICITY OF CERTAIN DERIVATIVES OF p-DIMETHYLAMINOAZOBENZENE IN THE RAT , 1948, The Journal of experimental medicine.

[12]  H. Druckrey,et al.  CHEMICAL STRUCTURE AND CARCINOGENICITY OF ALIPHATIC HYDRAZO, AZO, AND AZOXY COMPOUNDS AND OF TRIAZENES, POTENTIAL IN VIVO ALKYLATING AGENTS * , 1969 .

[13]  H. Richardson,et al.  Liver tumor inhibition and adrenal histologic responses in rats to which 3'-methyl-4-dimethylaminoazobenzene and 20-methylcholanthrene were simultaneously administered. , 1952, Cancer research.

[14]  S. Thorgeirsson,et al.  Mutagenic activation of N-hydroxy-2-acetylaminofluorene in the Salmonella test system: the role of deacetylation by liver and kidney fractions from mouse and rat. , 1978, Molecular pharmacology.

[15]  R. Boutwell,et al.  The function and mechanism of promoters of carcinogenesis. , 1974, CRC critical reviews in toxicology.

[16]  C. Heidelberger,et al.  The distribution of radioactivity in the mouse following administration of dibenzanthracene labeled in the 9 and 10 positions with carbon 14 , 1948, Cancer.

[17]  W. E. Scott,et al.  Isolation of the glucuronic acid conjugate of n-hydroxy-4-aminobiphenyl from dog urine and its mutagenic activity. , 1977, Cancer research.

[18]  E. Miller Some current perspectives on chemical carcinogenesis in humans and experimental animals: Presidential Address. , 1978, Cancer research.

[19]  E. Kriek,et al.  On the mechanism of action of carcinogenic aromatic amines. I. Binding of 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene to rat-liver nucleic acids in vivo. , 1969, Chemico-biological interactions.

[20]  J. Miller,et al.  Substrate-induced synthesis and other properties of benzpyrene hydroxylase in rat liver. , 1957, The Journal of biological chemistry.

[21]  J. Miller,et al.  Structures of hepatic nucleic acid-bound dyes in rats given the carcinogen N-methyl-4-aminoazobenzene. , 1975, Cancer research.

[22]  W. Haenszel,et al.  Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. , 1968, Journal of the National Cancer Institute.

[23]  M. S. Zedeck,et al.  Organ-specific effects of the carcinogen methylazoxymethanol related to metabolism by nicotinamide adenine dinucleotide-dependent dehydrogenases. , 1977, Cancer research.

[24]  P. Talalay,et al.  Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[25]  A. Dipple,et al.  Studies on the formation of hydrocarbon-deoxyribonucleoside products by the binding of derivatives of 7-methylbenz(a)anthracene to DNA in aqueous solution and in mouse embryo cells in culture. , 1973, Cancer research.

[26]  J. Miller,et al.  N-hydroxy-2-acetylaminofluorene sulfotransferase: its probable role in carcinogenesis and in protein-(methion-S-yl) binding in rat liver. , 1970, Cancer research.

[27]  J. Miller,et al.  3-methylmercapto-N-methyl-4-aminoazobenzene: an alkaline-degradation product of a labile protein-bound dye in the livers of rats fed N,N-dimethyl-4-aminoazobenzene. , 1965, Biochemical and biophysical research communications.

[28]  J. Miller,et al.  N-Benzoyloxy-N-methyl-4-aminoazobenzene: its carcinogenic activity in the rat and its reactions with proteins and nucleic acids and their constituents in vitro. , 1967, Cancer research.

[29]  J. Miller,et al.  Hepatic metabolism of N-hydroxy-N-methyl-4-aminoazobenzene and other N-hydroxy arylamines to reactive sulfuric acid esters. , 1976, Cancer research.

[30]  D. Jerina,et al.  Tumorigenicity of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8-diol-9,10-epoxides in newborn mice: exceptional activity of (+)-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[31]  C. King,et al.  Enzyme-Catalyzed Reactions of the Carcinogen N-Hydroxy-2-fluorenylacetamide with Nucleic Acid , 1968, Science.

[32]  A. Mattocks Toxicity of Pyrrolizidine Alkaloids , 1968, Nature.

[33]  L. Wattenberg Inhibitors of chemical carcinogenesis. , 1978, Advances in cancer research.

[34]  J. Huff,et al.  An evaluation of chemicals and industrial processes associated with cancer in humans based on human and animal data: IARC Monographs Volumes 1 to 20. , 1980, Cancer research.

[35]  C. Harris,et al.  Benzo(a)pyrene diol epoxides as intermediates in nucleic acid binding in vitro and in vivo. , 1976, Science.

[36]  B. Ames,et al.  Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals: discussion. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Mottram A developing factor in experimental blastogenesis , 1944 .

[38]  P. Grover,et al.  Enzyme-catalysed reactions of polycyclic hydrocarbons with deoxyribonucleic acid and protein in vitro. , 1968, The Biochemical journal.

[39]  B. Blumberg Australia antigen and the biology of hepatitis B. , 1977, Science.

[40]  P. Rous,et al.  CONDITIONAL NEOPLASMS AND SUBTHRESHOLD NEOPLASTIC STATES , 1941, The Journal of experimental medicine.

[41]  J. Weisburger,et al.  Chemistry, carcinogenicity, and metabolism of 2-fluorenamine and related compounds. , 1958, Advances in cancer research.

[42]  H. Gelboin A microsome-dependent binding of benzo[a]pyrene to DNA. , 1969, Cancer research.

[43]  D. Jerina,et al.  Benzo[a]pyrene 7,8-dihydrodiol is more carcinogenic than benzo[a]pyrene in newborn mice , 1977, Nature.

[44]  J. Miller,et al.  The reactivity and carcinogenicity of aflatoxin B1-2,3-dichloride, a model for the putative 2,3-oxide metabolite of aflatoxin B1. , 1975, Cancer research.

[45]  C. Heidelberger,et al.  Binding of K-region epoxides and other derivatives of benz(a)anthracene and dibenz(a,h)anthracene to DNA, RNA, and proteins of transformable cells. , 1972, Chemico-biological interactions.

[46]  S. Sorof,et al.  Evidence for a receptor protein of activated carcinogen. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[47]  R. C. Garner,et al.  The halogenation and attempted epoxidation of 3a,8a-dihydrofuro[2,3-b]benzofuran and aflatoxin B1 , 1979 .

[48]  E C Miller,et al.  Mechanisms of chemical carcinogenesis: nature of proximate carcinogens and interactions with macromolecules. , 1966, Pharmacological reviews.

[49]  J. Miller,et al.  Microsomal N-oxidation of the hepatocarcinogen N-methyl-4-aminoazobenzene and the reactivity of N-hydroxy-N-methyl-4-aminoazobenzene. , 1976, Cancer research.

[50]  C. Irving,et al.  Persistent binding of 2-acetylaminofluorene to rat liver DNA in vivo and consideration of the mechanism of binding of N-hydroxy-2-acetylaminofluorene to rat liver nucleic acids. , 1969, Cancer research.

[51]  A. Mattocks Dihydropyrrolizine derivatives from unsaturated pyrrolizidine alkaloids. , 1969, Journal of the Chemical Society. Perkin transactions 1.

[52]  J. Miller,et al.  Reactivity of the diacetyl derivative of the carcinogen 4-hydroxyaminoquinoline-1-oxide with DNA, RNA, and other nucleophiles. , 1968, Life sciences.

[53]  J. Miller,et al.  1'-Hydroxysafrole, a proximate carcinogenic metabolite of safrole in the rat and mouse. , 1973, Cancer research.

[54]  J. Miller,et al.  8-(N-2-fluorenylacetamido)guanosine, an arylamidation reaction product of guanosine and the carcinogen N-acetoxy-N-2-fluorenylacetamide in neutral solution. , 1967, Biochemistry.

[55]  F. Crick,et al.  Molecular Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid , 1953, Nature.

[56]  J. Miller,et al.  Reactions in vitro of some tissue nucleophiles with the glucuronide of the carcinogen N-hydroxy-2-acetylaminofluorene. , 1968, Molecular pharmacology.

[57]  J. Miller,et al.  Adducts from the reaction of N-benzoyloxy-N-methyl-4-aminoazobenzene with deoxyguanosine or DNA in vitro and from hepatic DNA of mice treated with N-methyl- or N,N-dimethyl-4-aminoazobenzene. , 1980, Cancer research.

[58]  H. Matsumoto,et al.  Studies on methylazoxymethanol, the aglycone of cycasin: methylation of nucleic acids in vitro. , 1966, The Biochemical journal.

[59]  S. A. Henry Occupational cutaneous cancer attributable to certain chemicals in industry. , 1946, British medical bulletin.

[60]  N. Mantel,et al.  Carcinogenicity testing of selected food additives by parenteral administration to infant Swiss mice. , 1970, Toxicology and applied pharmacology.

[61]  T. V. Wang,et al.  Spontaneous reactions of aflatoxin B1 modified deoxyribonucleic acid in vitro. , 1980, Biochemistry.

[62]  C. Heidelberger,et al.  An epoxide is an intermediate in the microsomal metabolism of the chemical carcinogen, dibenz(a,h)anthracene. , 1971, Biochemical and biophysical research communications.

[63]  J. Miller,et al.  In vivo combinations between carcinogens and tissue constituents and their possible role in carcinogenesis. , 1952, Cancer research.

[64]  A. Pegg Studies of the ethylation of rat liver transfer ribonucleic acid after administration of L-ethionine. , 1972, The Biochemical journal.

[65]  A. Haddow Sir Ernest Laurence Kennaway FRS, 1881-1958: Chemical Causation of Cancer Then and Today , 2015, Perspectives in biology and medicine.

[66]  EDWARD D. COPS,et al.  The Survival of the Fittest , 1872, Nature.

[67]  P. Shubik,et al.  Survey of Compounds Which Have Been Tested for Carcinogenic Activity , 1941 .

[68]  E C Miller,et al.  Structures of the DNA adducts formed in mouse liver after administration of the proximate hepatocarcinogen 1'-hydroxyestragole. , 1981, Cancer research.

[69]  J. Lefèvre,et al.  Comparative orientation of the fluorene residue in native DNA modified by N-acetoxy-N-2-acetylaminofluorene and two 7-halogeno derivatives. , 1976, Biochemistry.

[70]  J. Miller,et al.  Hepatic microsomal N-glucuronidation and nucleic acid binding of N-hydroxy arylamines in relation to urinary bladder carcinogenesis. , 1977, Cancer research.

[71]  E. Miller Studies on the formation of protein-bound derivatives of 3,4-benzpyrene in the epidermal fraction of mouse skin. , 1951, Cancer research.

[72]  J. Miller,et al.  The metabolic activation of carcinogenic aromatic amines and amides. , 1969, Progress in experimental tumor research.

[73]  J. Miller,et al.  Aflatoxin B1-2,3-oxide as a probable intermediate in the covalent binding of aflatoxins B1 and B2 to rat liver DNA and ribosomal RNA in vivo. , 1977, Cancer research.

[74]  J. Miller,et al.  N-hydroxy metabolites of 2-acetylaminophenanthrene and 7-fluoro-2-acetylaminofluorene as proximate carcinogens in the rat. , 1966, Cancer research.

[75]  J. Miller,et al.  The carcinogenic aminoazo dyes. , 1953, Advances in cancer research.

[76]  G. Williams,et al.  On the sulfate ester of N-hydroxy-N-2-fluorenylacetamide as a key ultimate hepatocarcinogen in the rat. , 1972, Cancer research.

[77]  L. S. Andrews,et al.  Studies on the mutagenicity of N-hydroxy-2-acetylaminofluorene in the Ames-Salmonella mutagenesis test system. , 1978, Biochemical pharmacology.

[78]  H. Pitot,et al.  The stages of initiation and promotion in hepatocarcinogenesis. , 1980, Biochimica et biophysica acta.

[79]  I. Berenblum The modifying influence of dichloro‐ethyl sulphide on the induction of tumours in mice by tar , 1929 .

[80]  E. Fiala,et al.  Inhibition of the metabolism of the colon carcinogen, azoxymethane, by pyrazole. , 1978, Cancer research.

[81]  C. King Mechanism of reaction, tissue distribution, and inhibition of arylhydroxamic acid acyltransferase. , 1974, Cancer research.

[82]  I. Berenblum The Cocarcinogenic Action of Croton Resin , 1941 .

[83]  J. Essigmann,et al.  Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[84]  J. Miller,et al.  The reductive cleavage of 4-dimethylaminoazobenzene by rat liver; the intracellular distribution of the enzyme system and its requirement for triphosphopyridine nucleotide. , 1949, The Journal of biological chemistry.

[85]  L. Sachs,et al.  Identification of mutagenic metabolites of benzo(a)pyrene in mammalian cells. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[86]  Miller Ec,et al.  The Carcinogenicity of p-Monomethylaminoazobenzene in Various Diets and the Activity of this Dye Relative to p-Dimethylaminoazobenzene , 1946 .

[87]  A. Pegg,et al.  Evidence for ethylation of rat liver deoxyribonucleic acid after administration of ethionine. , 1971, The Biochemical journal.

[88]  G. Wogan,et al.  Structure-activity relationships in toxicity and carcinogenicity of aflatoxins and analogs. , 1971, Cancer research.

[89]  H. Bartsch,et al.  On the metabolic activation of the carcinogen N-hydroxy-N-2-acetylaminofluorene. 3. Oxidation with horseradish peroxidase to yield 2-nitrosofluorene and N-acetoxy-N-2-acetylaminofluorene. , 1971, Biochimica et biophysica acta.

[90]  J. Miller,et al.  Liver microsomal metabolism of aflatoxin B 1 to a reactive derivative toxic to Salmonella typhimurium TA 1530. , 1972, Cancer research.

[91]  J. Miller,et al.  N-Hydroxylation: A new metabolic reaction observed in the rat with the carcinogen 2-acetylaminofluorene. , 1960, The Journal of biological chemistry.

[92]  J. Miller,et al.  The N- and ringhydroxylation of 2-acetylaminofluorene during carcinogenesis in the rat. , 1960, Cancer research.

[93]  J. Miller,et al.  Studies on structures of polar dyes derived from the liver proteins of rats fed N-methyl-4-aminoazobenzene. 3. Tyrosine and homocysteine sulfoxide polar dyes. , 1969, Biochemistry.

[94]  G. B. Brown,et al.  Oncogenic purine N-oxide derivatives as substrates for sulfotransferase. , 1973, Cancer research.

[95]  J. Miller,et al.  Sulfotransferase Activation of N-Hydroxy-2-acetylaminofluorene in Rodent Livers Susceptible and Resistant to this Carcinogen∗ , 1968, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[96]  J. Miller,et al.  Guanyl O6-arylamination and O6-arylation of DNA by the carcinogen N-hydroxy-1-naphthylamine. , 1978, Cancer research.

[97]  G. B. Brown,et al.  Oncogenic Purine Derivatives: Evidence for a Possible Proximate Oncogen , 1970, Science.

[98]  J. Miller,et al.  The Carcinogenicity of Certain Azo Dyes Related to p-Dimethylaminoazobenzene , 1945 .

[99]  C. Irving,et al.  Reaction of the glucuronide of the carcinogen N-hydroxy-2-acetylaminofluorene with nucleic acids. , 1969, Biochimica et biophysica acta.

[100]  J. Castro,et al.  Studies on the irreversible binding of 14 C-CCl 4 to microsomal lipids in rats under varying experimental conditions. , 1972, Toxicology and applied pharmacology.

[101]  J. Miller,et al.  Electrophilic N-acetoxyaminoarenes derived from carcinogenic N-hydroxy-N-acetylaminoarenes by enzymatic deacetylation and transacetylation in liver. , 1972, Biochimica et biophysica acta.

[102]  W. Lowrance,et al.  Of Acceptable Risk: Science and the Determination of Safety , 1976 .

[103]  G. Wogan,et al.  In vitro metabolism of aflatoxin B2 by animal and human liver. , 1978, Cancer research.

[104]  L. Fishbein,et al.  Identification of tertiary aminomethylenedioxy-propiophenones as urinary metabolites of safrole in the rat and guinea pig , 1971 .

[105]  P. Shubik,et al.  A New, Quantitative, Approach to the Study of the Stages of Chemical Carcinogenesis in the Mouse's Skin , 1947, British Journal of Cancer.

[106]  J. Miller,et al.  2,3-Dihydro-2,3-dihydroxy-aflatoxin B1: an acid hydrolysis product of an RNA-aflatoxin B1 adduct formed by hamster and rat liver microsomes in vitro. , 1973, Biochemical and biophysical research communications.

[107]  A. Hewer,et al.  Epoxides as microsomal metabolites of polycyclic hydrocarbons , 1971, FEBS letters.

[108]  C. Heidelberger Chemical oncogenesis in culture. , 1973, Advances in cancer research.

[109]  H. Butlin THREE LECTURES on CANCER of the SCROTUM in CHIMNEY-SWEEPS and OTHERS , 1892, British medical journal.

[110]  J. Miller,et al.  The metabolism of the naturally occurring hepatocarcinogen safrole to 1'-hydroxysafrole and the electrophilic reactivity of 1'-acetoxysafrole. , 1973, Cancer research.

[111]  E. Miller,et al.  The N-Hydroxylation of 4-Acetylaminobiphenyl by the Rat and Dog and the Strong Carcinogenicity of N-Hydroxy-4-acetylaminobiphenyl in the Rat , 1961 .

[112]  H. P. Rusch,et al.  Some Additive Effects of Carcinogenic Hydrocarbons , 1942 .

[113]  J. Kmet The role of migrant population in studies of selected cancer sites: a review. , 1970, Journal of chronic diseases.

[114]  J. Miller,et al.  N2 atom of guanine and N6 atom of adenine residues as sites for covalent binding of metabolically activated 1'-hydroxysafrole to mouse liver DNA in vivo. , 1981, Cancer research.

[115]  J. Miller,et al.  N-substitution of carbon 8 in guanosine and deoxyguanosine by the carcinogen N-benzoyloxy-N-methyl-4-aminoazobenzene in vitro. , 1975, Cancer research.

[116]  E. Hecker Structure-activity relationships in diterpene esters irritant and cocarcinogenic to mouse skin , 1978 .

[117]  B. Ames,et al.  Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[118]  T. Slaga,et al.  Marked differences in the tumor-initiating activity of optically pure (+)- and (-)-trans-7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene on mouse skin. , 1977, Cancer research.

[119]  J. Westra,et al.  Identification of the persistently bound form of the carcinogen N-acetyl-2-aminofluorene to rat liver DNA in vivo. , 1976, Chemico-biological interactions.

[120]  J. Miller,et al.  Aflatoxin B1-2,3-oxide: evidence for its formation in rat liver in vivo and by human liver microsomes in vitro. , 1974, Biochemical and biophysical research communications.

[121]  J. Poiley,et al.  Morphological transformation of early passage Golden Syrian Hamster embryo cells derived from cryopreserved primary cultures as a reliable in vitro bioassay for identifying diverse carcinogens , 1977, International journal of cancer.

[122]  A. Conney Pharmacological implications of microsomal enzyme induction. , 1967, Pharmacological reviews.

[123]  J. Miller,et al.  N-Hydroxy-2-acetylaminofluorene: a metabolite of 2-acetylaminofluorene with increased carcinogenic activity in the rat. , 1961, Cancer research.

[124]  E. Miller,et al.  Nucleic Acid Guanine: Reaction with the Carcinogen N-Acetoxy-2-Acetylaminofluorene , 1966, Science.

[125]  M. Horning,et al.  The metabolism of safrole and 2',3'-epoxysafrole in the rat and guinea pig. , 1974, Drug metabolism and disposition: the biological fate of chemicals.

[126]  J. Miller,et al.  Studies on structures of polar dyes derived from the liver proteins of rats fed N-methyl-4-aminoazobenzene. II. Identity of synthetic 3-(homocystein-S-yl)-N-methyl-4-aminoazobenzene with the major polar dye P2b. , 1968, Biochemistry.

[127]  E. Miller,et al.  Reaction of esters of aromatic N-hydroxy amines and amides with methionine in vitro: A model for in vivo binding of amine carcinogens to protein , 1966 .

[128]  J. Radomski The primary aromatic amines: their biological properties and structure-activity relationships. , 1979, Annual review of pharmacology and toxicology.

[129]  J. Miller,et al.  Mutations and decreases in density of transforming DNA produced by derivatives of the carcinogens 2-acetyl-aminofluorene and N-methyl-4-aminoazobenzene. , 1968, Molecular pharmacology.

[130]  E. Kriek On the interaction of N-2-fluorenylhydroxylamine with nucleic acids in vitro. , 1965, Biochemical and biophysical research communications.

[131]  J Bunyan,et al.  Treatment of Burns and Wounds by the Envelope Method , 1941, British medical journal.

[132]  J. Miller,et al.  Reactivity in vivo of the Carcinogen N-Hydroxy-2-acetylaminofluorene: Increase by Sulfate Ion , 1970, Science.

[133]  F. Beland,et al.  In vitro reaction of the carcinogen, N-hydroxy-2-naphthylamine, with DNA at the C-8 and N2 atoms of guanine and at the N6 atom of adenine. , 1980, Carcinogenesis.

[134]  J. Miller,et al.  CARCINOGENESIS AND INHIBITION OF THE WALKER 256 TUMOR IN THE RAT BY TRANS-4-ACETYLAMINOSTILBENE, ITS N-HYDROXY METABOLITE, AND RELATED COMPOUNDS. , 1964, Cancer research.

[135]  E. Miller,et al.  The Presence and Significance of Bound Aminoazo Dyes in the Livers of Rats Fed p-Dimethylaminoazobenzene , 1947 .

[136]  J. Miller,et al.  THE COMPARATIVE CARCINOGENICITIES OF 2-ACETYLAMINOFLUORENE AND ITS N-HYDROXY METABOLITE IN MICE, HAMSTERS, AND GUINEA PIGS. , 1964, Cancer research.

[137]  J. Miller,et al.  The metabolism of methylated aminoazo dyes. IV. Dietary factors enhancing demethylation in vitro. , 1954, The Journal of biological chemistry.

[138]  E C Miller,et al.  Hepatocarcinogenicity of estragole (1-allyl-4-methoxybenzene) and 1'-hydroxyestragole in the mouse and mutagenicity of 1'-acetoxyestragole in bacteria. , 1976, Journal of the National Cancer Institute.

[139]  C. Linsell,et al.  Dietary aflatoxins and human liver cancer. A study in Swaziland , 1976, International journal of cancer.

[140]  J. Miller,et al.  Biochemical investigations on hepatic carcinogenesis. , 1955, Journal of the National Cancer Institute.

[141]  R. C. Garner,et al.  Aflatoxin B-oxide generated by chemical or enzymic oxidation of aflatoxin B1 causes guanine substitution in nucleic acids , 1977, Nature.

[142]  J. Miller,et al.  2,3-Dihydro-2-(guan-7-yl)-3-hydroxy-aflatoxin B1, a major acid hydrolysis product of aflatoxin B1-DNA or -ribosomal RNA adducts formed in hepatic microsome-mediated reactions and in rat liver in vivo. , 1977, Cancer research.

[143]  A. Haddow,et al.  Chemistry of carcinogenic compounds. , 1946, British medical bulletin.

[144]  W. Lijinsky,et al.  Interaction of aflatoxins B1 and G1 with tissues of the rat. , 1970, Cancer research.

[145]  J. Miller,et al.  The metabolism of methylated aminoazo dyes. V. Evidence for induction of enzyme synthesis in the rat by 3-methylcholanthrene. , 1956, Cancer research.

[146]  C. King,et al.  Comparative effects of strain, species, and sex on the acyltransferase- and sulfotransferase-catalyzed activations of N-hydroxy-N-2-fluorenylacetamide. , 1975, Cancer research.

[147]  J. Miller,et al.  Carcinogenic and mutagenic activities of safrole, 1'-hydroxysafrole, and some known or possible metabolites. , 1977, Cancer research.

[148]  H. Rubin Is somatic mutation the major mechanism of malignant transformation? , 1980, Journal of the National Cancer Institute.

[149]  G. Miller,et al.  Tumorigenicity of embryonal carcinoma as an assay to study control of malignancy by the murine blastocyst. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[150]  K. Illmensee,et al.  Normal genetically mosaic mice produced from malignant teratocarcinoma cells. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[151]  C. Irving,et al.  Biliary excretion of the O-glucuronide of N-hydroxy-2-acetylamino-fluorene by the rat and rabbit. , 1967, Cancer research.

[152]  Freddy Homburger,et al.  The physiopathology of cancer , 1959 .

[153]  J. Miller,et al.  The metabolism of 4-dimethylaminoazobenzene by rat liver homogenates. , 1948, The Journal of biological chemistry.

[154]  F. Beland,et al.  Characterization of DNA adducts of the carcinogen N-methyl-4-aminoazobenzene in vitro and in vivo. , 1980, Chemico-biological interactions.

[155]  G. Mulder,et al.  Alteration of urinary levels of the carcinogen, N-hydroxy-2-naphthylamine, and its N-glucuronide in the rat by control of urinary pH, inhibition of metabolic sulfation, and changes in biliary excretion. , 1981, Chemico-biological interactions.

[156]  J. Miller,et al.  Studies on the protein-bound aminoazo dyes formed in vivo from 4-dimethylaminoazobenzene and its C-monomethyl derivatives. , 1949, Cancer research.

[157]  A. Hewer,et al.  Metabolic activation of benzo(a)pyrene proceeds by a diol-epoxide , 1974, Nature.

[158]  M S Legator,et al.  Chemical characterization of 465 known or suspected carcinogens and their correlation with mutagenic activity in the Salmonella typhimurium system. , 1979, Cancer research.

[159]  J. M. Blunck,et al.  Enhancement of azo dye carcinogenesis by dietary sodium sulphate. , 1975, European journal of cancer.

[160]  J. W. Flesher,et al.  Possible role of 6‐hydroxymethylbenzo[a]pyrene as a proximate carcinogen of benzo[a]pyrene and 6‐methylbenzo[a]pyrene , 1973, International journal of cancer.

[161]  D. Redmond Tobacco and cancer: the first clinical report, 1761. , 1970, The New England journal of medicine.